152 related articles for article (PubMed ID: 11310825)
1. Differential and mutually exclusive expression of CD95 and CD95 ligand in epithelia of normal pancreas and chronic pancreatitis.
Hasel C; Rau B; Perner S; Sträter J; Möller P
Lab Invest; 2001 Mar; 81(3):317-26. PubMed ID: 11310825
[TBL] [Abstract][Full Text] [Related]
2. CD95 ligand expression as a mechanism of immune escape in breast cancer.
Müschen M; Moers C; Warskulat U; Even J; Niederacher D; Beckmann MW
Immunology; 2000 Jan; 99(1):69-77. PubMed ID: 10651943
[TBL] [Abstract][Full Text] [Related]
3. Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatin.
Moers C; Warskulat U; Müschen M; Even J; Niederacher D; Josien R; Koldovsky U; Beckmann MW; Häussinger D
Int J Cancer; 1999 Feb; 80(4):564-72. PubMed ID: 9935158
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?
Strand S; Hofmann WJ; Hug H; Müller M; Otto G; Strand D; Mariani SM; Stremmel W; Krammer PH; Galle PR
Nat Med; 1996 Dec; 2(12):1361-6. PubMed ID: 8946836
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis.
Li JH; Kluger MS; Madge LA; Zheng L; Bothwell AL; Pober JS
Am J Pathol; 2002 Oct; 161(4):1485-95. PubMed ID: 12368221
[TBL] [Abstract][Full Text] [Related]
6. Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells.
Fulda S; Strauss G; Meyer E; Debatin KM
Blood; 2000 Jan; 95(1):301-8. PubMed ID: 10607716
[TBL] [Abstract][Full Text] [Related]
7. CD95 ligand-expressing tumors are rejected in anti-tumor TCR transgenic perforin knockout mice.
Behrens CK; Igney FH; Arnold B; Möller P; Krammer PH
J Immunol; 2001 Mar; 166(5):3240-7. PubMed ID: 11207278
[TBL] [Abstract][Full Text] [Related]
8. Differential susceptibility to HIV-GP120-sensitized apoptosis in CD4+ T-cell clones with different T-helper phenotypes: role of CD95/CD95L interactions.
Accornero P; Radrizzani M; Delia D; Gerosa F; Kurrle R; Colombo MP
Blood; 1997 Jan; 89(2):558-69. PubMed ID: 9002959
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection.
Cossarizza A; Stent G; Mussini C; Paganelli R; Borghi V; Nuzzo C; Pinti M; Pedrazzi J; Benatti F; Esposito R; Røsok B; Nagata S; Vella S; Franceschi C; De Rienzo B
AIDS; 2000 Mar; 14(4):345-55. PubMed ID: 10770536
[TBL] [Abstract][Full Text] [Related]
10. Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors. Implications for immune privilege and immune escape.
Bernstorff WV; Glickman JN; Odze RD; Farraye FA; Joo HG; Goedegebuure PS; Eberlein TJ
Cancer; 2002 May; 94(10):2552-60. PubMed ID: 12173320
[TBL] [Abstract][Full Text] [Related]
11. In chronic pancreatitis, widespread emergence of TRAIL receptors in epithelia coincides with neoexpression of TRAIL by pancreatic stellate cells of early fibrotic areas.
Hasel C; Dürr S; Rau B; Sträter J; Schmid RM; Walczak H; Bachem MG; Möller P
Lab Invest; 2003 Jun; 83(6):825-36. PubMed ID: 12808117
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis by IFNgamma in human neuroblastoma cell lines through the CD95/CD95L autocrine circuit.
Bernassola F; Scheuerpflug C; Herr I; Krammer PH; Debatin KM; Melino G
Cell Death Differ; 1999 Jul; 6(7):652-60. PubMed ID: 10453076
[TBL] [Abstract][Full Text] [Related]
13. Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in human embryonal carcinoma cells by interferon gamma and all-trans retinoic acid.
Müschen M; Warskulat U; Schmidt B; Schulz WA; Häussinger D
Biol Chem; 1998; 379(8-9):1083-91. PubMed ID: 9792441
[TBL] [Abstract][Full Text] [Related]
14. Defining CD95 as a tumor suppressor gene.
Müschen M; Warskulat U; Beckmann MW
J Mol Med (Berl); 2000; 78(6):312-25. PubMed ID: 11001528
[TBL] [Abstract][Full Text] [Related]
15. CD95 ligand: lethal weapon against malignant glioma?
Weller M; Kleihues P; Dichgans J; Ohgaki H
Brain Pathol; 1998 Apr; 8(2):285-93. PubMed ID: 9546287
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia.
Lamy T; Liu JH; Landowski TH; Dalton WS; Loughran TP
Blood; 1998 Dec; 92(12):4771-7. PubMed ID: 9845544
[TBL] [Abstract][Full Text] [Related]
17. CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants.
Eberle J; Fecker LF; Hossini AM; Wieder T; Daniel PT; Orfanos CE; Geilen CC
Oncogene; 2003 Dec; 22(57):9131-41. PubMed ID: 14668794
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of CD95 and CD95L mRNA expression in chronic and acute HIV-1 infection by competitive RT-PCR.
Pinti M; Nasi M; Moretti L; Mussini C; Petrusca D; Esposito R; Cossarizza A
Ann N Y Acad Sci; 2000; 926():46-51. PubMed ID: 11193040
[TBL] [Abstract][Full Text] [Related]
19. CD97, CD95 and Fas-L clearly discriminate between chronic pancreatitis and pancreatic ductal adenocarcinoma in perioperative evaluation of cryocut sections.
Boltze C; Schneider-Stock R; Aust G; Mawrin C; Dralle H; Roessner A; Hoang-Vu C
Pathol Int; 2002 Feb; 52(2):83-8. PubMed ID: 11940212
[TBL] [Abstract][Full Text] [Related]
20. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis.
Sträter J; Wellisch I; Riedl S; Walczak H; Koretz K; Tandara A; Krammer PH; Möller P
Gastroenterology; 1997 Jul; 113(1):160-7. PubMed ID: 9207274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
